FTC
- Share via
* For those of us who think that sending a complaint to a government agency is an exercise in futility, I have good news. Six months ago I wrote to the FTC about price gouging by the maker of a widely used anti-anxiety medication. I chalked it up as another wasted attempt at civic involvement.
Lo and behold (“Definitely a Cause of Anxiety,” editorial, Dec. 24), The Times reports that the FTC and 10 states are taking pharmaceutical giant Mylan Laboratories to court for price fixing to the tune of $120 million. Democracy in action. I’m speechless.
DANIEL SULLIVAN
San Diego
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
